AUPH
NASDAQ · Biotechnology
Aurinia Pharmaceuticals Inc
$16.35
+0.22 (+1.36%)
Open$16.23
Previous Close$16.13
Day High$16.38
Day Low$16.23
52W High$19.25
52W Low$10.34
Volume—
Avg Volume1.28M
Market Cap2.03B
P/E Ratio6.81
EPS$2.17
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+148.6% upside
Current
$16.35
$16.35
Target
$40.64
$40.64
$34.07
$40.64 avg
$61.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 253.38M | 197.48M | 554.79M |
| Net Income | 257.09M | 180.33M | -143,878,553 |
| Profit Margin | 101.5% | 96.4% | -25.9% |
| EBITDA | 111.32M | 82.42M | -183,212,536 |
| Free Cash Flow | — | — | -112,933,113 |
| Rev Growth | +28.3% | +28.3% | +6.7% |
| Debt/Equity | 0.12 | 0.12 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |